The following slide deck was published by Photocure ASA in conjunction with their 2023 Q4 earnings call.
For further details see:
Photocure ASA 2023 Q4 - Results - Earnings Call Presentationhome / stock / phcuf / phcuf news
The following slide deck was published by Photocure ASA in conjunction with their 2023 Q4 earnings call.
For further details see:
Photocure ASA 2023 Q4 - Results - Earnings Call PresentationMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Photocure Asa Company Name:
PHCUF Stock Symbol:
Market:
Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical Trial PR Newswire OSLO, Norway , Aug. 9, 2022 /PRNewswire/ -- On August 9, 2022 , Asieris Pharmaceuticals, a global biopharmaceutical company specializ...
Photocure ASA: Results for the first quarter of 2022 PR Newswire OSLO, Norway , May 11, 2022 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 81.4 million in the first quarter of 2022 (Q1 ...
Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in China PR Newswire OSLO, Norway , March 11, 2022 /PRNewswire/ -- Photocure ASA ( PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharm...